Pharma major Lupin has started to rationalise its R&D operations. The company has decided to scale down the drug discovery programme to focus on more near-term and mid-term opportunities. CNBC-TV18's Ekta Batra gave us more details.
Watch video for more…
Discover the latest Business News, Sensex, and Nifty updates. Obtain Personal Finance insights, tax queries, and expert opinions on Moneycontrol or download the Moneycontrol App to stay updated!